|
Atomistry » Fluorine » PDB 4j0v-4jps » 4jln | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Fluorine » PDB 4j0v-4jps » 4jln » |
Fluorine in PDB 4jln: Human Dck C4S-S74E Mutant in Complex with Udp and the F2.4.1 Inhibitor (2-[({2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Propyl-1,3-Thiazol-4- Yl}Methyl)Sulfanyl]Pyrimidine-4,6-Diamine)Enzymatic activity of Human Dck C4S-S74E Mutant in Complex with Udp and the F2.4.1 Inhibitor (2-[({2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Propyl-1,3-Thiazol-4- Yl}Methyl)Sulfanyl]Pyrimidine-4,6-Diamine)
All present enzymatic activity of Human Dck C4S-S74E Mutant in Complex with Udp and the F2.4.1 Inhibitor (2-[({2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Propyl-1,3-Thiazol-4- Yl}Methyl)Sulfanyl]Pyrimidine-4,6-Diamine):
2.7.1.74; Protein crystallography data
The structure of Human Dck C4S-S74E Mutant in Complex with Udp and the F2.4.1 Inhibitor (2-[({2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Propyl-1,3-Thiazol-4- Yl}Methyl)Sulfanyl]Pyrimidine-4,6-Diamine), PDB code: 4jln
was solved by
J.Nomme,
A.Lavie,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Human Dck C4S-S74E Mutant in Complex with Udp and the F2.4.1 Inhibitor (2-[({2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Propyl-1,3-Thiazol-4- Yl}Methyl)Sulfanyl]Pyrimidine-4,6-Diamine)
(pdb code 4jln). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 2 binding sites of Fluorine where determined in the Human Dck C4S-S74E Mutant in Complex with Udp and the F2.4.1 Inhibitor (2-[({2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Propyl-1,3-Thiazol-4- Yl}Methyl)Sulfanyl]Pyrimidine-4,6-Diamine), PDB code: 4jln: Jump to Fluorine binding site number: 1; 2; Fluorine binding site 1 out of 2 in 4jlnGo back to Fluorine Binding Sites List in 4jln
Fluorine binding site 1 out
of 2 in the Human Dck C4S-S74E Mutant in Complex with Udp and the F2.4.1 Inhibitor (2-[({2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Propyl-1,3-Thiazol-4- Yl}Methyl)Sulfanyl]Pyrimidine-4,6-Diamine)
Mono view Stereo pair view
Fluorine binding site 2 out of 2 in 4jlnGo back to Fluorine Binding Sites List in 4jln
Fluorine binding site 2 out
of 2 in the Human Dck C4S-S74E Mutant in Complex with Udp and the F2.4.1 Inhibitor (2-[({2-[3-(2-Fluoroethoxy)-4-Methoxyphenyl]-5-Propyl-1,3-Thiazol-4- Yl}Methyl)Sulfanyl]Pyrimidine-4,6-Diamine)
Mono view Stereo pair view
Reference:
J.Nomme,
J.M.Murphy,
Y.Su,
N.D.Sansone,
A.L.Armijo,
S.T.Olson,
C.Radu,
A.Lavie.
Structural Characterization of New Deoxycytidine Kinase Inhibitors Rationalizes the Affinity-Determining Moieties of the Molecules. Acta Crystallogr.,Sect.D V. 70 68 2014.
Page generated: Thu Aug 1 02:54:50 2024
ISSN: ISSN 0907-4449 PubMed: 24419380 DOI: 10.1107/S1399004713025030 |
Last articlesZn in 9JYWZn in 9IR4 Zn in 9IR3 Zn in 9GMX Zn in 9GMW Zn in 9JEJ Zn in 9ERF Zn in 9ERE Zn in 9EGV Zn in 9EGW |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |